"Meaningfully Useful" Risk Mitigation Strategies for Providers Following the eClinicalWorks Settlement

by Jones Day

Jones Day

In Short

The Situation: Recently, a leading electronic health records ("EHR") vendor entered into a $155 million settlement with the government to resolve allegations under the False Claims Act, and the United States Department of Health and Human Services' ("HHS") Office of Inspector General ("OIG") reported that the Centers for Medicare and Medicaid Services ("CMS") paid an estimated $729 million in Medicare EHR incentive payments from 2011–2014 that did not comply with federal requirements.

The Impact: There is heightened governmental scrutiny, and increasing liability, surrounding EHR meaningful use criteria and meaningful use incentive payments.

Looking Ahead: Health care providers should implement mitigation strategies to reduce regulatory risks with their EHR vendors and be prepared to respond to governmental audits of meaningful use attestations.

The Health Information Technology for Economic and Clinical Health Act ("HITECH Act") established financial incentives under Medicare and Medicaid for eligible health care providers that adopt, implement, and demonstrate use of certified EHR technologies to advance positive health outcomes consistent with identified meaningful uses. Given recent sizeable settlements, heightened regulatory oversight, and ongoing Medicare payment reform efforts relative to EHR meaningful use, health care providers should evaluate their risk exposure, including financial and legal liability, if EHR attestations are deemed inaccurate or unsubstantiated, or if the ongoing utilization of EHR technologies fails to meet program objectives.

DOJ Settlement with eClinicalWorks

On May 31, 2017, the United States Department of Justice ("DOJ") announced a $155 million settlement with eClinicalWorks ("ECW") to resolve allegations under the False Claims Act alleging that ECW misrepresented the capabilities of its EHR software. According to its website, ECW is a cloud-based EHR vendor with a customer base of more than 125,000 physicians and nurse practitioners, 850,000 users, and 70,000 facilities across all 50 U.S. states and 24 countries.

The government alleged that ECW falsely obtained meaningful use certification for its EHR software when it did not comply with applicable criteria. For example, according to the DOJ, ECW hardcoded a limited set of drug codes required to pass certification testing rather than programming the software to retrieve any drug code from a comprehensive database. ECW's software also failed to accurately record user actions in an audit log, reliably record diagnostic imaging orders, and satisfy data portability requirements. Because of such deficiencies, the government alleged that ECW caused the submission of false claims for meaningful use incentive payments.

OIG Report Scrutinizing EHR Incentive Payments

Within two weeks after the ECW settlement announcement, the OIG released a report finding that, from May 2011 through June 2014, CMS paid an estimated $729 million in Medicare EHR incentive payments (approximately 12 percent of all incentive payments paid during such time period) that did not comply with federal requirements.

As conveyed in the OIG report, the OIG determined that the EHR incentive payments program is susceptible to fraud and abuse, in part because CMS conducts minimal audits of self-attestations that health care providers submit when certifying compliance with meaningful use criteria. The OIG recommended, among other things, that CMS review a sample of health care providers' self-attestations to identify any inappropriate payments that may have been made after the audit period and educate health care providers on documentation requirements. Moreover, as CMS implements the Medicare Access & CHIP Reauthorization Act ("MACRA"), the OIG recommended that any modifications to meaningful use requirements include stronger safeguards for more consistent verification of reporting required measures in furtherance of MACRA's "advancing care information" goal.

Best Practices for Health Care Providers

The ECW settlement, the OIG report, and Medicare payment reform efforts, including MACRA, indicate that EHR meaningful use criteria are changing and likely to be the focus of ongoing governmental scrutiny. In fact, in response to an earlier draft of the OIG's report, CMS stated that it has implemented "targeted risk-based audits" to strengthen program integrity and will continue to do so in 2017. In light of this, health care providers should take immediate steps to implement mitigation strategies to reduce regulatory risks with their EHR vendors, as well as be prepared to respond thoroughly and timely to governmental audits of meaningful use attestations. In our view, the following strategies are critical to these efforts:

  • Remain fully informed of MACRA implementation efforts, including the requirements of the Advancing Care Information component of the Merit-based Incentive Payment System, as health information technology and EHR tools are key elements of such programs.
  • Negotiate specific representations and ongoing covenants in EHR vendor agreements appropriate to ensure the equipment and software purchased comply with basic meaningful use requirements and allow for potential future upgrades, if needed. Further, providers should consider indemnification and other risk-sharing provisions in the event technical aspects of the EHR result in flawed reports underlying meaningful use attestations, or the EHR is decertified by the Office of the National Coordinator for Health Information Technology ("ONC") after entering into the agreement.
  • Perform upfront and ongoing diligence of EHR technology and monitor the ONC website to identify any decertification announcements regarding vendor EHR technology.
  • Perform mock audits of meaningful use attestations and maintain complete, readily accessible, supporting documentation.
  • Consider engaging legal counsel to assist with developing appropriate policies, practices, and audit preparation strategies to ensure protection by the attorney-client privilege.

Three Key Takeaways

  1. Although the ECW settlement may be the first of its kind in the EHR context, the government continues to pursue cases under the False Claims Act against third-party vendors even though such vendors are not the direct recipients of federal funds.
  2. CMS is committed to strengthening Medicare and Medicaid program integrity, in part by increasingly engaging in governmental audits, particularly in the area of EHR meaningful use as it changes under MACRA payment reform efforts.
  3. Health care providers should develop comprehensive strategies to demonstrate appropriate ongoing EHR meaningful use and to substantiate related attestations so they can reduce the risks of negative audit findings, potential recoupment of EHR incentive payments, and other governmental enforcement actions, including under the False Claims Act.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Jones Day | Attorney Advertising

Written by:

Jones Day

Jones Day on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.